Show simple item record

dc.contributor.authorTang, S.
dc.contributor.authorPang, K. H.
dc.contributor.authorAlnajjar, H. M.
dc.contributor.authorAyres, B.
dc.contributor.authorKumar, V.
dc.contributor.authorParnham, Arie S
dc.contributor.authorMuneer, A.
dc.date.accessioned2023-03-20T15:44:02Z
dc.date.available2023-03-20T15:44:02Z
dc.date.issued2023en
dc.identifier.citationTang S, Pang KH, Alnajjar HM, Ayres B, Kumar V, Parnham A, et al. Videoendoscopic Inguinal Lymphadenectomy Versus Radical Open Dissection (VELRAD) in Patients with Male Genital Cancer: A Clinical Trial Update. Eur Urol Focus. 2023 Feb 14. PubMed PMID: 36797170. Epub 2023/02/17. eng.en
dc.identifier.pmid36797170en
dc.identifier.doi10.1016/j.euf.2023.01.018en
dc.identifier.urihttp://hdl.handle.net/10541/626071
dc.description.abstractVELRAD is the first multicentre feasibility randomised controlled trial comparing videoendoscopic radical inguinal lymphadenectomy versus open dissection for male genital cancer. We have randomised nine patients so far in our attempt to identify the best approach to inguinal lymph node dissection.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.euf.2023.01.018en
dc.titleVideoendoscopic inguinal lymphadenectomy versus radical open dissection (VELRAD) in patients with male genital cancer: a clinical trial updateen
dc.typeArticleen
dc.contributor.departmentUniversity College London Hospitals NHS Foundation Trust, London, UKen
dc.identifier.journalEuropean Urology Focusen
dc.description.noteen]


Files in this item

This item appears in the following Collection(s)

Show simple item record